| Application no. and date | 13744818.9 (espacenet) (Federated) (European Patent Register), 20130611 | | Patent/reg. no. and date | DK/EP 2858671, 20190724 | | Publication date | 20150415 | | Priority no. and date | US 201261658472 P, 20120612 | | EP pub. no. and date |
EP 2858671 20150415 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/159252 | | Inventor | COSENZA, Marta, Novartis Pharma AG
Werk Klybeck
Postfach
4002 Basel, CH,
STARK, Christoph, Novartis Pharma AG
Werk Klybeck
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Antistofformulering | | Int. application no. | IB2013054777 | | Int. publication no. | WO2013186700 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
